BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33862578)

  • 1. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution.
    Azizmohammad Looha M; Zarean E; Masaebi F; Pourhoseingholi MA; Zali MR
    Surg Oncol; 2021 Sep; 38():101562. PubMed ID: 33862578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Cut Point in the Age of Colorectal Cancer Diagnosis Using a Survival Cure Model.
    Abdollahi M; Kasiri N; Pourhoseingholi MA; Baghestani AR; Esmaily H
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2819-2823. PubMed ID: 31554382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer survival among Ministry of National Guard-Health Affairs (MNG-HA) population 2009-2017: retrospective study.
    Alyabsi M; Sabatin F; Ramadan M; Jazieh AR
    BMC Cancer; 2021 Aug; 21(1):954. PubMed ID: 34433443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality determinants in colorectal cancer patients at different grades: a prospective, cohort study in Iran.
    Ahmadi A; Mosavi-Jarrahi A; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2015; 16(3):1069-72. PubMed ID: 25735333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis.
    Asghari-Jafarabadi M; Hajizadeh E; Kazemnejad A; Fatemi SR
    Asian Pac J Cancer Prev; 2009; 10(5):815-21. PubMed ID: 20104971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an artificial neural network to determine prognostic factors in colorectal cancer patients.
    Gohari MR; Biglarian A; Bakhshi E; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2011; 12(6):1469-72. PubMed ID: 22126483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Rates and Associated Factors of Colorectal Cancer Patients in Brunei Darussalam.
    Leong E; Ong SK; Madli F; Tan A; Lai D; Basir N; Ramlee N; Chong VH
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):259-265. PubMed ID: 31983194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint modelling of colorectal cancer recurrence and death after resection using multi-state model with cured fraction.
    Alafchi B; Roshanaei G; Tapak L; Abbasi M; Mahjub H
    Sci Rep; 2021 Jan; 11(1):1016. PubMed ID: 33441746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of long-term cancer survivors and application of statistical cure models: a protocol for an observational follow-up study in patients with colorectal cancer.
    Pértega-Díaz S; Balboa-Barreiro V; Seijo-Bestilleiro R; González-Martín C; Pardeiro-Pértega R; Yáñez-González-Dopeso L; García-Rodríguez T; Seoane-Pillado T
    BMC Public Health; 2020 Nov; 20(1):1738. PubMed ID: 33203431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of Colorectal Cancer in the Presence of Competing- Risks - Modeling by Weibull Distribution.
    Baghestani AR; Daneshva T; Pourhoseingholi MA; Asadzadeh H
    Asian Pac J Cancer Prev; 2016; 17(3):1193-6. PubMed ID: 27039747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model.
    Zarean E; Azizmohammad Looha M; Amini P; Mahmoudi M; Azimi T
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1677-1683. PubMed ID: 29938465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prognostic factors effect on survival time in patients with colorectal cancer, based on Weibull Competing-Risks Model.
    Moamer S; Baghestani A; Pourhoseingholi MA; Hajizadeh N; Ahmadi F; Norouzinia M
    Gastroenterol Hepatol Bed Bench; 2017; 10(1):54-59. PubMed ID: 28331565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture cure model for estimating short-term and long-term colorectal cancer survival.
    Amanpour F; Akbari S; Azizmohammad Looha M; Abdehagh M; Pourhoseingholi MA
    Gastroenterol Hepatol Bed Bench; 2019; 12(Suppl1):S37-S43. PubMed ID: 32099600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.